BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3079028)

  • 1. Blood eosinophilia and renal allograft rejection.
    Frenken LA; Leunissen KM; van den Berg-Loonen PM; Kootstra G; van Hooff JP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1584-5. PubMed ID: 3079028
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine.
    Schulak JA; Moritz CE; Hricik DE
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
    Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
    [No Abstract]   [Full Text] [Related]  

  • 4. Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.
    Schilling M; Schleibner S; Abendroth D; Illner WD; Schneeberger H; Land W
    Transplant Proc; 1990 Oct; 22(5):2283. PubMed ID: 2219369
    [No Abstract]   [Full Text] [Related]  

  • 5. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
    Büsing M; Hölzer H; Schareck WD; Mellert J; Greger B; Hopt UT; Lauchart W
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1601-3. PubMed ID: 2652521
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation between blood eosinophilia and rejection crisis in renal transplants.
    Ianhez LE; Sabbaga J; de Araújo JF; de Paula FJ; Sabbaga E
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1586-8. PubMed ID: 3274389
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenal function as an index of the immunosuppressive activity of glucocorticoids (prednisolone) in renal allograft recipients.
    Kozaki M; Hirano T; Oka K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2237-9. PubMed ID: 3079076
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
    Renna Molajoni E; Bachetoni A; Cinti P; Sallustio F; Rossi M; Pretagostini R; Orlandini A; Berloco P; Alfani D; Cortesini R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of life on cyclosporine versus conventional therapy.
    Simmons RG; Abress LK
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1860-1. PubMed ID: 3079053
    [No Abstract]   [Full Text] [Related]  

  • 13. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
    Melzer JS; Husing RM; Feduska NJ; Tomlanovich SJ; Vincenti F; Amend WJ; Garovoy M; Salvatierra O
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1971-3. PubMed ID: 2856274
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
    Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
    Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
    [No Abstract]   [Full Text] [Related]  

  • 18. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract]   [Full Text] [Related]  

  • 19. Two-year fate of 100 kidney transplants treated with low-dose cyclosporine without biopsy guidelines.
    Civati G; Del Favero E; Brando B; Broggi ML; Busnach G; Forti D; Belli L; Minetti L
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1856-7. PubMed ID: 3079051
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine to azathioprine conversion in cadaveric renal transplants.
    Gonwa TA; Nghiem DD; Corry RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2018-20. PubMed ID: 3079068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.